Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Overview

Journal Hematol Oncol Clin North Am

Specialties Hematology
Oncology

Date 2008 Oct 29

PMID 18954751

Citations 9

Authors

David Wrench

John G Gribben

Affiliations

Soon will be listed here.

Abstract

Non-Hodgkin's lymphoma (NHL) includes a diverse set of conditions ranging from high-grade aggressive to more indolent low-grade disease. Hematopoietic stem cell transplantation (HSCT) has a valuable role in the management of these conditions and can provide long-term remission in selected cases. This article presents the current use of allogeneic and autologous HSCT in a number of subtypes of NHL.

Citing Articles

Long-term implications of autologous HCT for caregiver quality of life: how does the survivor's health matter?.

Stepanikova I, Powroznik K, Cook K, Tierney D, Laport G Support Care Cancer. 2018; 27(1):191-198.

PMID: 29926161 DOI: 10.1007/s00520-018-4311-1.

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders.

Fonseca-Hial A, Parisio K, Oliveira J Rev Bras Hematol Hemoter. 2016; 38(2):99-105.

PMID: 27208567 PMC: 4877659. DOI: 10.1016/j.bjhh.2016.02.006.

Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia.

Ossenkoppele G, Janssen J, Huijgens P Mediterr J Hematol Infect Dis. 2013; 5(1):e2013018.

PMID: 23505606 PMC: 3591258. DOI: 10.4084/MJHID.2013.018.

Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.

Lane A, Armand P, Feng Y, Neuberg D, Abramson J, Brown J Leuk Lymphoma. 2011; 53(6):1130-6.

PMID: 22132836 PMC: 3376378. DOI: 10.3109/10428194.2011.645208.

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.

Zimmerman Z, Scott B, Gopal A, Sandmaier B, Maloney D, Deeg H Bone Marrow Transplant. 2011; 47(6):804-9.

PMID: 21909142 PMC: 3237793. DOI: 10.1038/bmt.2011.180.